A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer
A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer
About this item
Full title
Author / Creator
Publisher
Boston, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
This study showed that a predictor based on gene expression provides prognostic information beyond that provided by traditional clinical predictors. It sets the stage for a prospective trial to determine whether the predictor could be used to guide the treatment of patients with stage IA non–small-cell lung cancer.
This study showed that a predi...
Alternative Titles
Full title
A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68726463
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68726463
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa060467
